ArticleBrain : a journal of neurology2022

Recurrent de novo mutations in CLDN5 induce an anion-selective blood-brain barrier and alternating hemiplegia.

Yosuke Hashimoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.